Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.

Rosen JB, Breman JG, Manclark CR, Meade BD, Collins WE, Lobel HO, Saliou P, Roberts JM, Campaoré P, Miller MA.

Malar J. 2005 Nov 6;4:53.

2.

Identification of Bordetella pertussis infection by shared-primer PCR.

Li Z, Jansen DL, Finn TM, Halperin SA, Kasina A, O'Connor SP, Aoyama T, Manclark CR, Brennan MJ.

J Clin Microbiol. 1994 Mar;32(3):783-9.

3.

Recent advances in the development of pertussis vaccines.

Brennan MJ, Burns DL, Meade BD, Shahin RD, Manclark CR.

Biotechnology. 1992;20:23-52. Review. No abstract available.

PMID:
1600382
4.

Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis.

Li ZM, Hannah JH, Stibitz S, Nguyen NY, Manclark CR, Brennan MJ.

Mol Microbiol. 1991 Jul;5(7):1649-56.

PMID:
1658537
5.

Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.

Arciniega JL, Hewlett EL, Johnson FD, Deforest A, Wassilak SG, Onorato IM, Manclark CR, Burns DL.

J Infect Dis. 1991 Jan;163(1):135-42.

PMID:
1984460
6.
7.

Inhibition of heat-labile toxin from Bordetella parapertussis by fatty acids.

Endoh M, Nagai M, Burns DL, Manclark CR, Nakase Y.

Infect Immun. 1990 Dec;58(12):4045-8.

8.

Development of a cell culture assay for Bordetella parapertussis heat-labile toxin.

Endoh M, Nagai M, Burns DL, Manclark CR, Nakase Y.

Biologicals. 1990 Oct;18(4):309-13.

PMID:
2285503
9.

Binding of ATP by pertussis toxin and isolated toxin subunits.

Hausman SZ, Manclark CR, Burns DL.

Biochemistry. 1990 Jul 3;29(26):6128-31.

PMID:
1698450
10.

Effects of exogenous agents on the action of Bordetella parapertussis heat-labile toxin on guinea pig skin.

Endoh M, Nagai M, Burns DL, Manclark CR, Nakase Y.

Infect Immun. 1990 May;58(5):1456-60.

11.

Determination of T cell epitopes on the S1 subunit of pertussis toxin.

Kim KJ, McKinness S, Manclark CR.

J Immunol. 1990 May 1;144(9):3529-34.

PMID:
1691761
12.

Purification and analysis of the antigenicity of a 69,000 Da protein from Bordetella pertussis.

Gould-Kostka JL, Burns DL, Brennan MJ, Manclark CR.

FEMS Microbiol Lett. 1990 Feb;55(3):285-9.

PMID:
2323550
13.
14.

Binding of pertussis toxin to eucaryotic cells and glycoproteins.

Witvliet MH, Burns DL, Brennan MJ, Poolman JT, Manclark CR.

Infect Immun. 1989 Nov;57(11):3324-30.

15.

Pertussis in a previously immunized child with human immunodeficiency virus infection.

Adamson PC, Wu TC, Meade BD, Rubin M, Manclark CR, Pizzo PA.

J Pediatr. 1989 Oct;115(4):589-92. No abstract available.

PMID:
2795352
16.
17.

Immune response to dimeric subunits of the pertussis toxin B oligomer.

Hausman SZ, Burns DL, Sickler VC, Manclark CR.

Infect Immun. 1989 Jun;57(6):1760-4.

18.

Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies.

Kim KJ, Burnette WN, Sublett RD, Manclark CR, Kenimer JG.

Infect Immun. 1989 Mar;57(3):944-50.

19.

Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function.

Kenimer JG, Kim KJ, Probst PG, Manclark CR, Burstyn DG, Cowell JL.

Hybridoma. 1989 Feb;8(1):37-51.

PMID:
2466764
20.

Role of cysteine 41 of the A subunit of pertussis toxin.

Burns DL, Manclark CR.

J Biol Chem. 1989 Jan 5;264(1):564-8.

21.

Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.

Brennan MJ, Li ZM, Cowell JL, Bisher ME, Steven AC, Novotny P, Manclark CR.

Infect Immun. 1988 Dec;56(12):3189-95.

22.

Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.

Li ZM, Brennan MJ, David JL, Carter PH, Cowell JL, Manclark CR.

Infect Immun. 1988 Dec;56(12):3184-8.

23.

Sensitivity and specificity of clinical case definitions for pertussis.

Patriarca PA, Biellik RJ, Sanden G, Burstyn DG, Mitchell PD, Silverman PR, Davis JP, Manclark CR.

Am J Public Health. 1988 Jul;78(7):833-6.

24.

Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation.

Baraff LJ, Shields WD, Beckwith L, Strome G, Marcy SM, Cherry JD, Manclark CR.

Pediatrics. 1988 Jun;81(6):789-94.

PMID:
3259305
25.

Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein.

Brennan MJ, David JL, Kenimer JG, Manclark CR.

J Biol Chem. 1988 Apr 5;263(10):4895-9.

26.

Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled.

Steketee RW, Wassilak SG, Adkins WN Jr, Burstyn DG, Manclark CR, Berg J, Hopfensperger D, Schell WL, Davis JP.

J Infect Dis. 1988 Mar;157(3):434-40.

PMID:
3257783
27.

A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled.

Steketee RW, Burstyn DG, Wassilak SG, Adkins WN Jr, Polyak MB, Davis JP, Manclark CR.

J Infect Dis. 1988 Mar;157(3):441-9.

PMID:
2893828
28.

Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.

Li ZM, Cowell JL, Brennan MJ, Burns DL, Manclark CR.

Infect Immun. 1988 Mar;56(3):699-702.

29.

Outbreaks of pertussis in the United States: the Wisconsin experience.

Partiarca PA, Steketee RW, Biellik RJ, Wassilak SG, Brink EW, Burstyn DG, Manclark CR, Davis JP.

Tokai J Exp Clin Med. 1988;13 Suppl:117-23.

PMID:
3273611
30.

Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis.

Brennan MJ, Li ZM, Shahin RD, Burns DL, Nguyen NY, Liu TY, Gray MC, Hewlett EL, Manclark CR.

Tokai J Exp Clin Med. 1988;13 Suppl:211-5.

PMID:
2908522
31.

Biochemical properties of pertussis toxin.

Burns DL, Hausman SZ, Witvliet MH, Brennan MJ, Poolman JT, Manclark CR.

Tokai J Exp Clin Med. 1988;13 Suppl:181-5.

PMID:
2856219
32.

Structural characterization of pertussis toxin A subunit.

Burns DL, Hausman SZ, Lindner W, Robey FA, Manclark CR.

J Biol Chem. 1987 Dec 25;262(36):17677-82.

33.

Immune response to the B oligomer of pertussis toxin.

Arciniega JL, Burns DL, Garcia-Ortigoza E, Manclark CR.

Infect Immun. 1987 May;55(5):1132-6.

34.

Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.

Cowell JL, Zhang JM, Urisu A, Suzuki A, Steven AC, Liu T, Liu TY, Manclark CR.

Infect Immun. 1987 Apr;55(4):916-22.

35.
36.
37.

Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents.

Moss J, Stanley SJ, Watkins PA, Burns DL, Manclark CR, Kaslow HR, Hewlett EL.

Biochemistry. 1986 May 6;25(9):2720-5.

PMID:
2872921
38.

Characterization of the filamentous hemagglutinin from Bordetella pertussis by gel electrophoresis.

An der Lan B, Cowell JL, Burstyn DG, Manclark CR, Chrambach A.

Mol Cell Biochem. 1986 Apr;70(1):31-55.

PMID:
2872590
39.

Adenine nucleotides promote dissociation of pertussis toxin subunits.

Burns DL, Manclark CR.

J Biol Chem. 1986 Mar 25;261(9):4324-7.

40.

Prospects for a new acellular pertussis vaccine.

Manclark CR, Burns DL.

Ann Inst Pasteur Microbiol (1985). 1985 Nov-Dec;136B(3):323-9.

PMID:
2870676
41.

Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line.

Backlund PS Jr, Meade BD, Manclark CR, Cantoni GL, Aksamit RR.

Proc Natl Acad Sci U S A. 1985 May;82(9):2637-41.

42.

Purification and characterization of fimbriae isolated from Bordetella pertussis.

Zhang JM, Cowell JL, Steven AC, Carter PH, McGrath PP, Manclark CR.

Infect Immun. 1985 May;48(2):422-7.

43.

Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.

Oda M, Cowell JL, Burstyn DG, Thaib S, Manclark CR.

Infect Immun. 1985 Feb;47(2):441-5.

44.

DTP vaccine reactions: effect of prior reactions on rate of subsequent reactions.

Baraff LJ, Cherry JD, Cody CL, Marcy SM, Manclark CR.

Dev Biol Stand. 1985;61:423-8.

PMID:
3879687
45.
46.
47.

Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.

Zhang JM, Cowell JL, Steven AC, Manclark CR.

Dev Biol Stand. 1985;61:173-85.

PMID:
2872103
48.
50.

Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies.

Davis LE, Burstyn DG, Manclark CR.

Pediatr Infect Dis. 1984 Sep-Oct;3(5):448-51. No abstract available.

PMID:
6093068

Supplemental Content

Loading ...
Support Center